The microRNA in ventricular remodeling: the miR-30 family.


Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
30 08 2019
Historique:
received: 28 03 2019
revised: 07 07 2019
accepted: 16 07 2019
pubmed: 20 7 2019
medline: 15 9 2020
entrez: 20 7 2019
Statut: epublish

Résumé

Ventricular remodeling (VR) is a complex pathological process of cardiomyocyte apoptosis, cardiac hypertrophy, and myocardial fibrosis, which is often caused by various cardiovascular diseases (CVDs) such as hypertension, acute myocardial infarction, heart failure (HF), etc. It is also an independent risk factor for a variety of CVDs, which will eventually to damage the heart function, promote cardiovascular events, and lead to an increase in mortality. MicroRNAs (miRNAs) can participate in a variety of CVDs through post-transcriptional regulation of target gene proteins. Among them, microRNA-30 (miR-30) is one of the most abundant miRNAs in the heart. In recent years, the study found that the miR-30 family can participate in VR through a variety of mechanisms, including autophagy, apoptosis, oxidative stress, and inflammation. VR is commonly found in ischemic heart disease (IHD), hypertensive heart disease (HHD), diabetic cardiomyopathy (DCM), antineoplastic drug cardiotoxicity (CTX), and other CVDs. Therefore, we will review the relevant mechanisms of the miR-30 in VR induced by various diseases.

Identifiants

pubmed: 31320543
pii: BSR20190788
doi: 10.1042/BSR20190788
pmc: PMC6680373
pii:
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019 The Author(s).

Références

Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1635-41
pubmed: 11959625
J Surg Res. 2004 Jan;116(1):91-7
pubmed: 14732353
Hum Mol Genet. 2006 Aug 1;15(15):2285-97
pubmed: 16782803
Circulation. 2007 May 8;115(18):2451-7
pubmed: 17485594
Circ Res. 2009 Jan 30;104(2):170-8, 6p following 178
pubmed: 19096030
Prog Cardiovasc Dis. 2009 Sep-Oct;52(2):153-67
pubmed: 19732607
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):716-23
pubmed: 20110569
Genome Biol. 2011 Jul 18;12(7):R64
pubmed: 21767385
Hypertension. 2012 Jan;59(1):76-84
pubmed: 22068868
Clin Physiol Funct Imaging. 2012 Mar;32(2):133-8
pubmed: 22296634
PLoS One. 2012;7(2):e31279
pubmed: 22348065
PLoS One. 2012;7(8):e42542
pubmed: 22880027
Blood. 2012 Dec 13;120(25):5063-72
pubmed: 23086751
J Biol Chem. 2013 Jan 11;288(2):859-72
pubmed: 23184933
PLoS One. 2013;8(1):e53950
pubmed: 23326547
J Card Fail. 2013 Apr;19(4):283-94
pubmed: 23582094
Diabetes Metab Syndr Obes. 2013 Apr 11;6:151-60
pubmed: 23610527
Mol Cell Biochem. 2013 Jul;379(1-2):1-6
pubmed: 23660952
Circulation. 2013 Jul 23;128(4):388-400
pubmed: 23877061
J Pathol. 2014 Feb;232(3):308-18
pubmed: 24132643
Br J Pharmacol. 2014 Apr;171(8):2080-90
pubmed: 24147975
Trends Endocrinol Metab. 2014 Mar;25(3):156-64
pubmed: 24370004
Biochim Biophys Acta. 2015 Feb;1852(2):252-61
pubmed: 24882754
Thromb Haemost. 2014 Nov;112(5):893-900
pubmed: 25104210
Endocrinology. 2014 Nov;155(11):4581-90
pubmed: 25137026
Antioxid Redox Signal. 2015 Jan 20;22(3):224-40
pubmed: 25203395
World J Cardiol. 2014 Sep 26;6(9):968-84
pubmed: 25276298
Chest. 2014 Oct;146(4):1123-1130
pubmed: 25288002
Cell Death Dis. 2014 Oct 23;5:e1479
pubmed: 25341033
Mol Biosyst. 2015 Jan;11(1):239-51
pubmed: 25361207
Circulation. 2015 Mar 3;131(9):795-804
pubmed: 25637627
Cardiovasc Ther. 2015 Jun;33(3):89-97
pubmed: 25781190
Int J Hypertens. 2015;2015:169069
pubmed: 25861465
Oxid Med Cell Longev. 2015;2015:234104
pubmed: 25918579
Cell Death Dis. 2015 May 07;6:e1754
pubmed: 25950484
Tumour Biol. 2015 Jul 25;:null
pubmed: 26209295
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67
pubmed: 26386112
Biomed Rep. 2015 Sep;3(5):668-674
pubmed: 26405543
J Clin Invest. 2015 Nov 2;125(11):4091-106
pubmed: 26436650
J Mol Cell Cardiol. 2015 Nov;88:111-9
pubmed: 26456066
Cell Physiol Biochem. 2015;37(4):1369-78
pubmed: 26488467
Eur Heart J. 2016 Feb 7;37(6):572-6
pubmed: 26553540
Clin Sci (Lond). 2015 Dec;129(12):1173-93
pubmed: 26561593
J Transl Med. 2015 Nov 16;13:363
pubmed: 26572862
Oncol Rep. 2016 Mar;35(3):1757-63
pubmed: 26708607
Int J Clin Exp Pathol. 2015 Dec 01;8(12):15527-36
pubmed: 26884822
Cardiovasc Diabetol. 2016 Mar 22;15:49
pubmed: 27005938
Ann Transl Med. 2016 Apr;4(7):144
pubmed: 27162794
Mol Cell Biochem. 2016 Jun;417(1-2):191-203
pubmed: 27221738
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):141-154
pubmed: 27297622
J Nucl Cardiol. 2017 Apr;24(2):574-590
pubmed: 27480973
Life Sci. 2017 Jan 15;169:69-75
pubmed: 27633839
Biosci Biotechnol Biochem. 2017 Jan;81(1):119-126
pubmed: 27729002
Cell Death Dis. 2016 Nov 24;7(11):e2477
pubmed: 27882943
Int J Cardiol. 2017 Mar 15;231:201-206
pubmed: 27889210
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F589-F598
pubmed: 27974319
Cell Physiol Biochem. 2016;40(6):1325-1333
pubmed: 27997912
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):1904-1911
pubmed: 28069395
J Mol Cell Cardiol. 2017 Mar;104:1-8
pubmed: 28108310
J Am Heart Assoc. 2017 Feb 10;6(2):
pubmed: 28188250
Lancet. 2017 Jul 22;390(10092):400-414
pubmed: 28190577
Cell Physiol Biochem. 2017;41(3):973-986
pubmed: 28222434
Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):2070-2077
pubmed: 28344129
Tumour Biol. 2017 Mar;39(3):1010428317692204
pubmed: 28347244
Expert Rev Mol Med. 2017 Apr 5;19:e5
pubmed: 28376937
Antioxid Redox Signal. 2019 Jun 20;30(18):2110-2153
pubmed: 28398124
BMC Cardiovasc Disord. 2017 May 23;17(1):132
pubmed: 28535761
J Mol Med (Berl). 2017 Aug;95(8):887-898
pubmed: 28540409
Sci Rep. 2017 Jun 7;7(1):2957
pubmed: 28592847
Circulation. 2017 Aug 29;136(9):834-848
pubmed: 28642276
Tumour Biol. 2017 Jun;39(6):1010428317703984
pubmed: 28651493
J Mol Cell Cardiol. 2017 Aug;109:1-16
pubmed: 28668302
Med Hypotheses. 2017 Jul;104:20-24
pubmed: 28673582
Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2642-2649
pubmed: 28678320
Oxid Med Cell Longev. 2017;2017:7921363
pubmed: 28698769
Cutan Ocul Toxicol. 2018 Jun;37(2):121-126
pubmed: 28707489
Biomed Pharmacother. 2017 Sep;93:1253-1260
pubmed: 28738542
Biochem Biophys Res Commun. 2017 Sep 30;491(4):946-952
pubmed: 28757413
Diabetologia. 2018 Jan;61(1):21-28
pubmed: 28776083
Cell Death Dis. 2017 Aug 10;8(8):e2987
pubmed: 28796263
Cardiol J. 2018;25(6):722-731
pubmed: 28840590
Clin Exp Pharmacol Physiol. 2018 Jan;45(1):68-74
pubmed: 28925510
Adv Clin Exp Med. 2017 Aug;26(5):865-874
pubmed: 29068585
Cell Physiol Biochem. 2017;43(6):2405-2419
pubmed: 29073630
Am J Transl Res. 2017 Nov 15;9(11):5150-5159
pubmed: 29218112
Antioxid Redox Signal. 2018 Mar 20;28(9):735-740
pubmed: 29278923
Exp Ther Med. 2018 Jan;15(1):599-605
pubmed: 29375703
Front Immunol. 2018 Feb 05;8:1977
pubmed: 29459855
Biochem Biophys Res Commun. 2018 May 5;499(2):128-135
pubmed: 29501491
Am J Cardiovasc Dis. 2018 Feb 05;8(1):1-13
pubmed: 29531852
Int J Mol Med. 2018 Jun;41(6):3221-3230
pubmed: 29532851
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Microbiome. 2018 Apr 3;6(1):66
pubmed: 29615110
J Cell Physiol. 2018 Sep;233(9):7343-7355
pubmed: 29663360
Med Sci Monit. 2018 Jun 11;24:3958-3965
pubmed: 29889825
Int J Obes (Lond). 2018 Jun;42(6):1140-1150
pubmed: 29899524
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jun 24;46(6):450-457
pubmed: 29925181
Oncol Lett. 2018 Jul;16(1):1173-1179
pubmed: 29963192
Biomed Res Int. 2018 May 29;2018:9623412
pubmed: 30003109
J Cell Biochem. 2018 Nov;119(11):9519-9531
pubmed: 30129221
Sci Rep. 2018 Oct 2;8(1):14638
pubmed: 30279543
J Cell Physiol. 2019 Jun;234(6):8834-8845
pubmed: 30317638
Biomed Pharmacother. 2019 Jan;109:71-83
pubmed: 30396094
Curr Pharm Des. 2018;24(37):4391-4396
pubmed: 30501597
Front Immunol. 2018 Nov 21;9:2631
pubmed: 30524425
Exp Ther Med. 2018 Dec;16(6):5286-5297
pubmed: 30542486
Echocardiography. 2019 Mar;36(3):486-494
pubmed: 30632188
Heart Fail Rev. 2019 Jul;24(4):575-586
pubmed: 30710255
Can J Physiol Pharmacol. 2019 Jun;97(6):581-588
pubmed: 30730762
Food Chem Toxicol. 2019 Mar;125:503-519
pubmed: 30735749
J Am Heart Assoc. 2019 Feb 19;8(4):e010926
pubmed: 30764689
Int J Biochem Cell Biol. 2019 Jul;112:39-49
pubmed: 30978403
Heart Fail Rev. 2019 Sep;24(5):743-758
pubmed: 31209771

Auteurs

Xiaonan Zhang (X)

Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Shaoyang Dong (S)

Department of Orthopaedics, Affiliated Hospital of Hebei College of Traditional Chinese Medicine, Hebei 050011, China.

Qiujin Jia (Q)

Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Ao Zhang (A)

Department of Epidemiology, College of global public health, New York University, 726 broad way, New York, NY 10003, U.S.A.

Yanyang Li (Y)

Department of Integrated Traditional Chinese and Western Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300193, China.

Yaping Zhu (Y)

Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

Shichao Lv (S)

Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 372272027@qq.com tjzhtcm@163.com.

Junping Zhang (J)

Department of Cardiovascular Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 372272027@qq.com tjzhtcm@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH